BackCell Source Overview

Cell Source Receivables

Track Cell Source's receivables ($50K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$50000.00

Peer trimmed avg / median

Loading

Cell Source Receivables History

Loading

Cell Source vs. peers: Receivables Comparison

Loading

Cell Source Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cell Source (CLCS) FAQ

Cell Source posts a receivables of $50K as of December 2024. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Cell Source's receivables was $0. The latest reading is $50K (period ending December 2024). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of Cell Source's financial statement story. At $50K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CLCS's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Cell Source's other metric pages and overview cover the third.

Judging Cell Source against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in receivables easier to interpret. Start with $50K here, then scan peer and history charts to see if the gap is persistent.